- Home
- WSBC vs ZLAB Comparison
WSBC vs ZLAB Comparison
Compare WSBC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- ZLAB
- Stock Information
- Founded
- WSBC 1870
- ZLAB 2013
- Country
- WSBC United States
- ZLAB China
- Employees
- WSBC N/A
- ZLAB N/A
- Industry
- WSBC Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- WSBC Finance
- ZLAB Health Care
- Exchange
- WSBC Nasdaq
- ZLAB Nasdaq
- Market Cap
- WSBC 2.9B
- ZLAB 3.2B
- IPO Year
- WSBC N/A
- ZLAB 2017
- Fundamental
- Price
- WSBC $30.39
- ZLAB $20.56
- Analyst Decision
- WSBC Buy
- ZLAB Buy
- Analyst Count
- WSBC 5
- ZLAB 6
- Target Price
- WSBC $39.60
- ZLAB $57.22
- AVG Volume (30 Days)
- WSBC 507.2K
- ZLAB 912.2K
- Earning Date
- WSBC 10-22-2025
- ZLAB 11-06-2025
- Dividend Yield
- WSBC 4.86%
- ZLAB N/A
- EPS Growth
- WSBC N/A
- ZLAB N/A
- EPS
- WSBC 2.04
- ZLAB N/A
- Revenue
- WSBC $804,347,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- WSBC $42.29
- ZLAB $40.71
- Revenue Next Year
- WSBC $20.56
- ZLAB $50.42
- P/E Ratio
- WSBC $14.90
- ZLAB N/A
- Revenue Growth
- WSBC 41.87
- ZLAB 24.14
- 52 Week Low
- WSBC $26.42
- ZLAB $20.13
- 52 Week High
- WSBC $37.36
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- WSBC 44.97
- ZLAB 20.57
- Support Level
- WSBC $29.75
- ZLAB $21.59
- Resistance Level
- WSBC $31.92
- ZLAB $22.28
- Average True Range (ATR)
- WSBC 0.70
- ZLAB 0.81
- MACD
- WSBC 0.01
- ZLAB -0.13
- Stochastic Oscillator
- WSBC 33.56
- ZLAB 5.49
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.